(Q33860155)

29 July 2017

title

Outcome assessment of minimizing vancomycin monitoring and dosing adjustments (English)

1 reference

29 July 2017

1 reference

Karam CM

1 reference

29 July 2017

McKinnon PS

series ordinal

1 reference

29 July 2017

Neuhauser MM

series ordinal

1 reference

29 July 2017

Rybak MJ

series ordinal

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

257-266

1 reference

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Monitoring serum vancomycin levels: climbing the mountain because it is there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Vancomycin pharmacokinetics in burn patients and intravenous drug abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Altered vancomycin dose vs. serum concentration relationship in burn patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Pharmacokinetics of vancomycin in patients with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Vancomycin pharmacokinetics in patients with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Clinical pharmacology and efficacy of vancomycin in pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

The pharmacokinetics of aztreonam and penetration into the bronchial secretions of critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

A prospective study of adverse reactions associated with vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

A simplified dosing method for initiating vancomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Why monitor peak vancomycin concentrations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.257.30933

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1128/AAC.23.1.138

Identifiers

DOI

10.1592/PHCO.19.4.257.30933

1 reference

release_3ti4l2kb7nfovaemk535lq333e

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3ti4l2kb7nfovaemk535lq333e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference